Results 41 to 50 of about 2,128,083 (311)

The COSMAM TRIAL a prospective cohort study of quality of life and cosmetic outcome in patients undergoing breast conserving surgery

BMC Cancer, 2018
Background Cosmetic result in breast cancer surgery is gaining increased interest. Currently, some 30–40% of the patients treated with breast conserving surgery (BCS) are dissatisfied with their final cosmetic result.
Coriene J. L. M. Catsman, Martinus A. Beek, Adri C. Voogd, Paul G. H. Mulder, Ernest J. T. Luiten   +4 more
doaj   +1 more source

Comparison of Oncoplastic Breast-Conserving Surgery and Breast-Conserving Surgery Alone: A Meta-Analysis

Journal of Breast Cancer, 2018
The use of oncoplastic reconstruction for breast-conserving surgery (BCS) extends benefits beyond merely minimizing poor cosmetic results. However, the feasibility and oncological safety of oncoplastic surgery (OPS) are controversial.This meta-analysis aimed to compare the short-term and long-term oncological outcomes of BCS alone and BCS plus OPS ...
Chen, Jun-Ying, Huang, Yi-Jie, Zhang, Liu-Lu, Yang, Ci-Qiu, Wang, Kun   +4 more
openaire   +2 more sources

Versatility of therapeutic reduction mammoplasty in oncoplastic breast conserving surgery [PDF]

, 2015
Oncoplastic breast conserving surgery is the gold standard approach for the surgical treatment of early breast cancer. There is a well defined technique named “therapeutic mammoplasty” which is characterized for using a reduction mammaplasty technique
González Noriega, Mónica, Gómez Fleitas, Manuel, Hernanz de la Fuente, Fernando Luis, Vázquez Pérez, Rocio   +3 more
core  

Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress [PDF]

, 2017
We, the Korean Breast Cancer Society (KBCS), present the facts and the trends of breast cancer in Korea in 2014. Data on the total number of newly diagnosed patients was obtained from the Korea Central Cancer Registry database, other data were collected ...
박병우
core   +1 more source

Comparing costs of standard Breast-Conserving Surgery to Oncoplastic Breast-Conserving Surgery and Mastectomy with Immediate two-stage Implant-Based Breast Reconstruction

, 2022
Background: Conventional breast-conserving surgery (C-BCS) has equal oncological outcomes and superior cosmetic and patient-reported outcomes compared to mastectomy with immediate two-stage implant-based breast reconstruction (M-IBR).
Witmer, Tom J.K., Bargon, Claudia A., de Leeuw, Daniëlle M., Rakhorst, Hinne A., Koiter, Eveline, Kouwenberg, Casimir A.E., Siemerink, Ester J.M., Mureau, Marc A.M.; id_orcid, Mureau, Marc A.M.   +8 more
core   +1 more source

Cancer‐associated mutations in endometriosis reframe a benign disease through molecular oncology

Molecular Oncology, EarlyView.
This review aims to comprehensively analyse cancer‐associated somatic mutations (CAMs) present in endometriotic lesions, emphasizing their biological roles, spatial distribution and implications for translational applications in medicine. By contextualizing a benign state within a genomic framework, this analysis seeks to establish its value as a ...
Clarissa Mujacic, Maria Concetta Vitale, Rita Siino, Emilia Di Giovanni, Carla Ferrante Bannera, Enrico Di Marco, Andrea Gottardo, Tancredi Didier Bazan Russo, Nadia Barraco, Alessandro Perez, Valerio Gristina, Antonio Galvano, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan, Lorena Incorvaia   +15 more
wiley   +1 more source

Patient satisfaction after unilateral oncoplastic volume displacement surgery for breast cancer, evaluated with the BREAST-Q™

World Journal of Surgical Oncology, 2019
Background Oncoplastic breast-conserving surgery allows larger resections in unfavorable locations, with an improved chance of preserving esthetics. Indications and timing for potential contralateral surgery to obtain symmetry are not clear.
Anna Gardfjell, Cecilia Dahlbäck, Kristina Åhsberg   +2 more
doaj   +1 more source

A Cross-Sectional Study of Breast Cancer Surgery and the Cost Based on Data From 77 Chinese 3A Hospitals in 2015

Frontiers in Oncology, 2022
PurposesWe aimed to clarify the real-world status of breast cancer surgery and the cost in China.MethodsThis cross-sectional survey relied on data obtained from the hospitalization summary reports (HSRs) in 77 top-ranked (grade 3A) hospitals in China to ...
Rong Zhao, Meng Jin, Jinnan Gao, Linhui Zhang, Liyuan Tao, Liyuan Tao, Xiaoyuan Bao   +6 more
doaj   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Predictive factors for breast conserving surgery after neoadjuvant chemotherapy in breast cancer

World Journal of Surgical Oncology
Background Neoadjuvant chemotherapy has several advantages, including reducing the number of mastectomies. Breast conserving surgeries avoid certain complications and sequelae, reduces hospital stays and improves patients’ quality of life and aesthetics.
Julie Berna, Sophie Michel, Leila Bouazzi, Vivien Ceccato, Lauren Darrigues, Elodie Gauroy, Enora Laas, Julie Rosa, Emilie Raimond, Imane Menouer, Olivier Graesslin, Thomas Gaillard, Fabien Reyal, Coralie Barbe, Judicael Hotton   +14 more
doaj   +1 more source